Received: 16 April 2019
Accepted: 23 August 2019
First Online: 29 August 2019
Ethics approval and consent to participate
: The Ethics Committee of the University Heidelberg approved the analysis of clinical data and of genetic polymorphisms (S-500/2016).
: Written informed consent was obtained from the patient for publication of her anonymized clinical details.
: AH reports no competing interests.CGG reports no competing interests.CD reports no competing interests.KIF reports no competing interests.JB reports no competing interests.JW reports no competing interests.DC reports no competing interests.JP received consulting honoraria, speakers’ honoraria and travel support from BMS Pfizer, Boehringer Ingelheim, Akcea.TR received consulting honoraria, speakers’ honoraria and travel support from BMS Pfizer, Boehringer Ingelheim, Bayer HealthCare and Daiichi Sankyo, outside the submitted work.WEH received consulting honoraria, speaker’s honoraria and travel support from BMS, Boehringer Ingelheim, and Daiichi Sankyo and research support from Bayer, BMG, and Daichii-Sankyo outside the submitted work.